Clinical Trial Update: SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether adding fluoxetine to immunotherapy improves outcomes in patients with advanced hepatobiliary cancer who also h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatobiliary Cancer

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Hepatobiliary Malignancy, Fluoxetine | Phase 2 | Status: RECRUITING